- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD) in Singapore
Total 7 results
-
Singapore National Eye CentreBayerCompletedAge Related Macular Degeneration | Polypoidal Choroidal VasculopathySingapore
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
Hoffmann-La RocheRecruitingNeovascular Age-related Macular Degeneration (nAMD)Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
-
BayerRegeneron PharmaceuticalsActive, not recruitingNeovascular Age-Related Macular DegenerationUnited States, Spain, Korea, Republic of, Czechia, Japan, Singapore, China, Serbia, Lithuania, Taiwan, Australia, Estonia, Austria, Israel, France, Italy, Switzerland, Slovakia, Ukraine, Bulgaria, Portugal, Latvia, Canada, Hungary, Arge... and more
-
Hoffmann-La RocheRecruitingDiabetic Macular Edema | Neovascular Age-related Macular DegenerationGermany, Japan, United Kingdom, Spain, United States, Italy, Switzerland, Canada, France, Australia, Singapore, Puerto Rico, United Arab Emirates, Bulgaria, Croatia, Chile
-
Singapore Eye Research InstituteUniversity of Melbourne; Curtin University; Singapore National Eye Centre; Ministry...UnknownGlaucoma | Diabetic Retinopathy | Age-related Macular Degeneration | Low Vision | Chronic DiseasesSingapore
-
Novartis PharmaceuticalsCompletedDiabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionSpain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more